Pharmaceutical R&D
Daewoong Pharma Adopts ‘Mini Liver’ for Drug Toxicity
Kwon Seok-yoon, President of the Korea Research Institute of Bioscience and Biotechnology (left), and Park Sung-soo, CEO of Daewoong Pharmaceutical, pose for a commemorative photo after signing a technology transfer agreement for liver organoid production and drug evaluation at the Magok Research Ce
2026.07.15